Sami B. Nazzal
Cardiology | Interventional Cardiology
374 E Vanderbilt Way
San Bernardino, CA 92408
San Bernardino, CA 92408
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Development of BMX siRNA lipid nanoparticles using novel ionizable and cleavable lipids discovered through AI and experimentation for cancer therapy.
Journal: International journal of pharmaceutics
Published: July 17, 2025
AI & experimental-based discovery and preclinical IND-enabling studies of selective BMX inhibitors for development of cancer therapeutics.
Journal: International journal of pharmaceutics
Published: June 13, 2023
Compounding Education in US PharmD Curricula.
Journal: American journal of pharmaceutical education
Published: August 29, 2022
Sustained release of curcumin self-emulsifying drug delivery system (SEDDS) from solvent-cast Soluplus® films.
Journal: Pharmaceutical development and technology
Published: October 14, 2021
Preparation and characterization of aqueous vitamin E/Soluplus® dispersions for film coating applications.
Journal: Drug development and industrial pharmacy
Published: October 08, 2021
Modulation of the sublingual microenvironment and pH-dependent transport pathways to enhance atropine sulfate permeability for the treatment of organophosphates poisoning.
Journal: International journal of pharmaceutics
Published: May 11, 2021
A full factorial experimental design to study the effect of flavoring agents on the mechanical properties of curcumin chewing gum tablets with high solids content.
Journal: Drug development and industrial pharmacy
Published: February 25, 2020
Development and evaluation of paclitaxel nanoemulsion for cancer therapy.
Journal: Pharmaceutical development and technology
Published: December 21, 2019
Gold nanoparticles and angiogenesis: molecular mechanisms and biomedical applications.
Journal: International journal of nanomedicine
Published: July 20, 2019
Novel olive oil phenolic (-)-oleocanthal (+)-xylitol-based solid dispersion formulations with potent oral anti-breast cancer activities.
Journal: International journal of pharmaceutics
Published: May 19, 2019
Ceramide-Rubusoside Nanomicelles, a Potential Therapeutic Approach to Target Cancers Carrying p53 Missense Mutations.
Journal: Molecular cancer therapeutics
Published: April 04, 2019
Last Updated: 09/26/2026